E Fund Management Co., Ltd. Mirum Pharmaceuticals, Inc. Transaction History
E Fund Management Co., Ltd.
- $1.93 Billion
- Q3 2024
A detailed history of E Fund Management Co., Ltd. transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 5,491 shares of MIRM stock, worth $260,987. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,491Holding current value
$260,987% of portfolio
0.01%Shares
4 transactions
Others Institutions Holding MIRM
# of Institutions
193Shares Held
54.1MCall Options Held
177KPut Options Held
167K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$312 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.48MShares$213 Million0.09% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.45MShares$164 Million2.37% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$154 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.08MShares$146 Million3.81% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.75B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...